Aveanna Healthcare Holdings Inc. (AVAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Benjamin Rossi
JPMorgan Chase & Co, Research Division

Thank you all for joining us here in person. For those who are joining us via webcast, my name is Ben Rossi, and I’m the health care facilities analyst here at JPMorgan. We are excited to welcome Aveanna back to the stage this morning. With us here today are CEO, Jeff Shaner, and CFO, Matt Buckhalter. Thank you both for being here.

Jeffrey Shaner
CEO & Director

Thanks, Ben, and good morning. As Ben said, I’m Jeff Shaner, the CEO of Aveanna Healthcare, and I’m here today with Matt Buckhalter, our Chief Financial Officer.

We’re going to kick into our presentation and what we’ll get [ wrong ]. But we’re pleased to share Aveanna story with you today and provide updates on our 2025 trends and also give initial insight into how we’re thinking about 2026. I would like to point out, as Ben knows, we filed an 8-K and press release early this morning, and we plan to cover the details during today’s presentation.

Specifically, we will comment on our updated 2025 guidance, our 2025 bridge to normalize adjusted EBITDA and our initial 2026 guidance. With that, we’ll jump in to our investor deck on Slide 3.

We believe that scale and density of health care services help support our value proposition. And at Aveanna, we are a leading scaled national provider of health care services. Further, our diversified platform provides pediatric, adult and geriatric services cared for by almost 30,000 caregivers in 30 states — 38 states, excuse me. Also, our national platform is